Marvin White

Latest stories

29d
The Seattle Times
Seattle biotech Aptevo Therapeutics spins off from parent as public companyfor our employees by delivering on our mission to extend and meaningfully impro
Seattle biotech Aptevo Therapeutics spins off from parent as public company
The Seattle Times / Posted 29 days ago
for our employees by delivering on our mission to extend and meaningfully improve patients’ lives,” Aptevo CEO Marvin White said in a statement. The biotech’s public debut marks the third IPO for Washington state companies in 2016,... Read more

People in this news